Gilead’s Yeztugo drug for HIV prevention in adults gets FDA nod
HQ Team June 19, 2025: Gilead Sciences, Inc.’s twice-yearly injectable drug for the prevention of HIV in adults and adolescents got approval from.
Uncategorized